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ABSTRACT 
 
Hyperlipidemia can lead to disorders that result in the onset of various diseases, including cardiovascular diseases 
which are the leading cause of death in many industrialized countries. Antioxidants are recommended in the 
treatment of various diseases, particularly atherosclerosis. However, the results of the studies are inconclusive and 
do not provide strong evidence that antioxidants have a substantial effect on disease. From the results of the studies 
presented in this paper it might be concluded that although antioxidants might be beneficial in patients with 
atherosclerosis or other cardiovascular diseases, however, single or even combination of a few antioxidants are 
not reliable agents for this purpose. This might be due to the complexity of free radicals which are produced and 
work as a continuous chain. It is known that after scavenging electron, if an antioxidant is not restored by the 
following antioxidant in the chain, it usually changes to a pro-oxidant. In this situation, the final effect of such 
supplementation would be no or a damaging effect. In this review study, other than presenting and discussing the 
studied antioxidants on hyperlipidemia and cardiovascular diseases, the possible reasons for the opposing actions 
of different antioxidants are discussed in detail.  
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INTRODUCTION 
 
Hyperlipidemia has been shown to contribute in development and severity of atherosclerosis and cardiovascular 
diseases. The level of cholesterol transporting by lipoproteins like chylomicrons, the very-low-density lipoproteins 
(VLDL) and the low density lipoproteins (LDL), is a risk factor for the incidence of cardiovascular disease [1]. 
 
 Lipids in the cell membrane, act as energy storage, additionally, act as hormones and secondary messengers. Plasma 
lipid concentrations at any time reflect the balance between production, storage and consumption. Cardiovascular 
diseases are considered as the leading cause of death in many industrialized countries [2]. The prevalence of 
hyperlipidemia in the world is 15.2% [3]. Hyperlipidemia as a major risk factor for cardiovascular system directly or 
indirectly increases the production of oxygen free radicals and thus the progress of atherosclerosis plaques causing 
cardiovascular and of coronary artery atherosclerotic [2, 4]. 
 
Free radicals are considered as constant threats to the human bodies [5]. Free radicals are wide groups of highly 
reactive molecules which may cause damage to cell structures. Reactive oxygen species (ROS) are considered as the 
most abundant free radicals which are usually formed as natural byproducts of normal metabolism in the body.  ROS 
have crucial role in homeostasis and cell signaling [6]. 
 
Free radicals are present and produced in many chemical configurations, shapes and sizes. They all have high 
Mahmoud Bahmani et al Der Pharmacia Lettre, 2015, 7 (12):81-88 
______________________________________________________________________________ 
82 
Scholar Research Library 
appetite to capture electrons and stealing them from any nearby substances. Free radicals can damage the 
instructions of DNA or oxidize the molecule of circulating low-density lipoprotein (LDL), making it suitable to be 
trapped in an artery wall [7].   
 
If we consider that free radicals can accelerate atherosclerosis, hence antioxidants should be able to prevent 
atherosclerosis [8,9]. However, some large clinical trials have declared that antioxidants have no positive effect and 
even sometimes destructing effects have been observed. In contrast, a lot of medicinal plants have been shown to 
possess antioxidant activity and seem to be effective substances and good source for new drugs [10, 11]. Herbs have 
a long history of use [12] and most of them have few side effects [13]. These substances in addition to 
hyperlipidemia, are used in prevention [13,14] or treatment [15,16] of other cardiovascular disorders [17,18], as well 
as in many other incurable diseases like diabetes [19,20], hypertension [21,22], ulcers and burns [23,24], bacterial 
diseases [25,26], cancer [27,28] or parasitic infections [29,30]. Herbs can also confront the toxic effects of other 
drugs [31,32]or toxins [33,34].  
 
In this review study, other than presenting and discussing the studied antioxidants on hyperlipidemia and 
cardiovascular diseases [35,36], the possible reasons for the opposing actions of different antioxidants are discussed 
in detail.  
 
The role of antioxidant supplementation on atherosclerosis and heart disease 
The role of vitamins C or E, beta-carotene and other complementary antioxidants against heart disease and stroke 
are not as they were hoping for. Large vitamin E trials on patients with coronary disease or at high risk for it, have 
shown no benefit.  In a large study, about 40000 healthy women were administered placebo or 600 IU of vitamin E 
every other day. The incidence of cardiovascular events was not significant different control group and those took 
vitamin E for 10 years. However, there was 24 percent reduction in total cardiovascular mortality which may 
represent an important outcome [37]. 
 
In another study, the rate of cardiovascular events was not different in placebo (20.6 percent and  vitamin E (21.5 
percent) groups, However, the participants who took vitamin E had higher risks of heart failure and hospitalization 
for heart failure [38]. In another trial, the results showed no preventive effects after more than three years 
consumption of  vitamin E among heart attack survivors [39] Beta-carotene, which is an antioxidant, also did not 
show any significant effect against heart disease or stroke [40]. 
 
In contrast to the above mentioned papers, in a recently published trial in Middle East, vitamin E resulted in a 
significant reduction in coronary heart disease among people with type 2 diabetes mellitus [41]. Notably, different 
isoforms of tocopherol (vitamin E isoforms) have shown contrasting effects on lung function this study 
demonstrated that higher level of serum alpha tocopherol was associated with higher spirometric parameters, 
however, high level of serum gamma tocopherol was associated with lower spirometric parameters. The same results 
may be achieved in hyperlipidemia [42]. 
 
In antioxidant combination studies the results are complicated, too. In French, 13,000 people who took a single daily 
capsule of placebo or the one containing 120 mg vitamin C, 30 mg vitamin E, 6 mg beta-carotene, 20 mg zinc and 
100 mg selenium for more than seven years showed no significant effect on overall rates of cardiovascular disease 
[43]. In another study the combination of vitamin C, vitamin E, and/or beta-carotene showed the same effect as a 
placebo on coronary revascularization, stroke, myocardial infarction or cardiovascular death [44]. 
 
RESULTS 
 
Effects of medicinal plants with antioxidant activity on hyperlipidemia 
Recently a rapid rise is seen in the use of medicinal plants for the treatment of hyperlipidemia which may indicate 
that botanical supplements can prevent atherosclerosis [1,45]. The ant i -hyperlipidemic activities of plants have 
been evaluated and confirmed in a lot of animal Models, and human beings. Some clinical trials have also 
confirmed that foods rich in antioxidants may play an essential role in the prevention of cardiovascular disease 
[46,47]. Consumption of Cereals, plant sterols and stanols as well as viscous soluble dietary fibers is recommended. 
Hence the information on some plants which their antioxidant a n d  hypolipidemic activities have been 
confirmed are presented in table 1. 
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Table 1. Medicinal plants with antioxidant activity used in hyperlipidemia 
 
Row Scientific name of Plant Therapeutic effect References 
1 Amirkabiria odorastissima 
Mozaffarian 
Reducing blood lipids in hypercholesterolemic rabbit model [48] 
2 Rheum ribes L Stimulating liver and gall bladder, regulation the blood cholesterol .In clinical 
studies, consumption 27 gram of stem of Rheum ribes L for four weeks caused 
the decrease in cholesterol and LDL. 
[49] 
3 Pistacia atlantica Feeding 20 percent of the Pistacia atlantica in period 3 weeks led to reduction in 
cholesterol- LDL   
[50] 
4 Allium sativum L. Consumption of garlic and the garlic coated tablets caused the decrease in 
cholesterol and LDL . Garlic caused the decrease in formation 
of Atherosclerosis. 
[51,52] 
5 Guggul (Commiphora mukul) 
 
Receiving 100 mg daily for 12 weeks Guggul caused the decreased total 
cholesterol to the amount of 12. 7 percent ,   LDL 12.7 % , triglycerides 12% and 
the ratio of cholesterol to LDL decreased about 11.1 %. 
[53] 
6 Trigonella foenum graecum L. Consumption of a warm extraction of plant for 2 months caused the decrease in 
serum triglycerides. 
[54] 
7 Red yeast rice Stimulating blood cycle and digestion by thought-provoking secretion and 
increase HDL and reduce triglycerides and LDL . 
[55] 
8 Cynara scolymus Stimulating the liver and gallbladder and bile secretion and is prescribed to 
reduce cholesterol levels. Improves digestion problems due to lack of bile 
secretion and increased secretion of bile to help digest fats. Inhibit cholesterol 
synthesis in the liver cells and protects the liver from chemical toxins damage. 
[56] 
9 Cyamopsis tetragonoloba (Guar 
gum) 
Reduce intestinal absorption of fat in food and fecal steroid excretion and bile 
production increased by using this plant. 
[57] 
10 Oat Leading to lower LDL cholesterol levels and inhibiting LDL oxidation and 
antioxidant properties which are dose dependent. 
[58] 
11 L-cavanin Alfalfa seeds reduce blood cholesterol levels. Regular use of old alfalfa seed for 
one year by monkey, reduce cholesterol levels and no side effects from it yet 
Report. 
[59] 
12 Silybum marianum L. LDL cholesterol levels were reduced by 10%,  LDL / HDL ratio improves and 
also reduces triglyceride levels. 
[60] 
13 Dietary fiber Effects of dietary fiber on blood lipid dropping in both laboratory and clinical 
research has proven. 
[61] 
14 Glycine max L. 
 
Medicinal plant Silybum marianum seed extract (silymarin) is an herbal remedy 
to lowering blood cholesterol in patients with hypercholesterolemia. Silymarin 
also reduces blood cholesterol and increase the HDL. 
[62] 
15 Juglans regia Anti-lipid effects of walnuts in humans has been demonstrated. [63] 
16 Brassica napus L Cooked turnip extract decrease triglycerides, cholesterol, LDL-cholesterol and 
the level of HDL-Cholesterol increases. 
[64] 
17 Citrus extracts Short-term and long-term consumption of grapefruit, orange and pineapple 
(citrus) on lipids and lipoproteins were determined in normolipidemic mice. In 
short term period, plasma triglycerides were reduced with consumption pineapple 
and grapefruit, but did not change the amount of total cholesterol and VLDL. 
Citrus fruits such as orange juice include an excellent food source of hydrophilic 
and lipophilic phytochemicals. Pectin is a soluble fiber found in citrus fruits that 
are capable of binding and uptake of bile acids and has the ability to form high 
viscosity solutions. This increases the viscosity of gastrointestinal tumors. 
Finally, the level of total cholesterol improved in patients hypercholestrolemic. 
[65,66] 
18 Solanum lycopersicum 
& 
Solanum Melongena 
Tomatoes, nightshade and husk tomato contain lycopene, which is effective in 
the treatment of hypertension and reduction the risk of heart disease. Because 
lycopene and fiber prevents bad cholesterol of blood and possibly increased 
wasting by releasing of cholesterol and thereby reduces blood cholesterol levels. 
 A Glycoalkaloid steroid in tomatoes reduces the low-density lipoprotein 
cholesterol, but does not cause the change the high-density lipoprotein 
cholesterol concentrations. The fruit of this plant (husk tomato) contain ascorbic 
acid, citric acid and sugar and vitamin C content of this plant is about twice 
comparison the lemons. Fruit of Physalis alkekengi in traditional medicine have 
been prescribed orally as a diuretic and to treat kidney stones and jaundice. Most 
plants in this family such as eggplant, reduce blood cholesterol levels, this effect 
was not only due to niacin (a powerful antioxidant), but also because of their 
phytotrines (phenolic compounds, acids cafic and cholovegeniac) is in addition 
to the alkaloid, inhibits cholesterol synthesis. 
[67-69] 
19 Ginseng Daily intake of 150 mg per kg body weight of ginseng extract for 6 weeks in rats 
reduced 40% cholesterol. 
[70] 
20 Brassica Oleraceae Italica Broccoli sprout powder has a positive effect in improving blood lipid levels in 
diabetic patients. So that daily consumption of 10 grams of broccoli sprouts for 4 
weeks caused a significant 13.5% reduction in triglycerides and a significant 
increase in HDL-C in patients with type 2 diabetes is. The 12.2% decrease in 
total cholesterol at the end of four weeks, a significant reduction occurred in the 
ratio of total cholesterol to cholesterol- LDL, cholesterol - LDL to cholesterol-
HDL. 
[71] 
21 Olea europaea Olive oil consumption increased HDL, decreased LDL and cholesterol, reducing 
triglycerides and LDL-cholesterol ratio. 
[72] 
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22 Sesamus indicum 
 
Daily consumption of 30 grams of sesame oil for 6 weeks caused a significant 
reduction in total cholesterol, LDL, fasting blood glucose and glycosylated 
hemoglobin in type II diabetics. 
[73] 
23 Citrus limetta Studies show that rats fed lemon peel have concluded the lower level liver and 
plasma cholesterol, which suggested this decrease is related to the flavonoids. 
[74] 
24 Saccharum officinarum Hamsters fed policosanol revealed 25-15% reduction of serum total cholesterol 
and increased HDL-Cholestrol levels by as much as 16.8 to 7 percent. 
[75] 
 
DISCUSSION 
 
Antioxidants are important part of diets for patients with hypercholesterolemia [76]. However, the results of the 
studies are inconclusive and do not provide strong evidence that antioxidants have a substantial effect on disease. 
From the results of the studies presented in this paper it might be concluded that although antioxidants might be 
beneficial in patients with hyperlipidemia or other cardiovascular diseases, however, single or even combination of 
a few antioxidants are not reliable agents for this purpose [37-44]. 
 
Free radicals have been shown to contribute to a wide range of complications including atherosclerosis [77,78]. 
diabetes mellitus [79,80], cognitive and other neurological disorders [81-87] and infectious diseases [88-96]. The 
results of preclinical and clinical trials, especially, the results of cohort studies do not show that all compounds with 
antioxidant activities will definitely fix the problem. Some scientists believe that antioxidants do not exert benefit 
when they are prepared synthetically or when taken out of their natural context [37-44]. 
 
Abundant evidence suggests that consumption of medicinal plants, whole grains, vegetables, and fruits, rich in 
antioxidants provide protection against these complications [97-100]. They possess a wide variety of 
phytochemicals with antioxidant activities including flavonoids, tocopherols, tannins, anthocyanins, carotenoids, as 
well as vitamins C and E [101-105]. All of these have antioxidant activities which can help prevent atherosclerosis. 
However, they have some other compounds which may act by various mechanisms to reduce cardiovascular 
diseases [106-108]. 
 
Polyphenols donate phenolic hydrogen atoms to free radicals and inhibit the oxidation of lipids and proteins. 
Flavonoids decrease the apo B secretion in hepatocytes by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A 
(HMG CoA). Tannins enhance the synthesis of nitric oxide, which relaxes the vascular segments. Anthocyanins 
suppress the genes involved in proliferation, angiogenesis and inflammation. They also inhibit oxidation of low 
density lipoproteins. Vitamins C and E prevent membrane peroxidation by scavenging free radical species 
[109,110]. 
 
Medicinal plants with these and some other compounds as well as antioxidant activities have been shown to be 
effective against a wide range of diseases [111-115]. The reason for contrasting actions of different antioxidants on 
oxidative stress induced complications is an important question which should be answered.    
 
Free radicals are substances which come in a wide variety of configurations, shapes and sizes. They have appetite to 
steal electrons from any nearby substances. However, this happens as redox reaction or oxidation-reduction reaction. 
Redox reaction has some similarities to acid-base reaction. Redox reaction is a reaction which causes transfer of 
electron between different species. Reduction refers to the gain and oxidation refers to the loss of electron. Redox 
reaction, the same as acid-base reactions, is a matched set. It means that we have an oxidation reaction and a 
reduction reaction which happen at the same time [6,116].  
 
The balance between generation and elimination of free radicals is maintained by several complex mechanisms. 
Dysfunction of these mechanisms usually leads to alterations in cellular redox status. An increase in production of 
free radical or a decrease in the scavenging of free radical disrupts redox homeostasis, leading to oxidative stress. 
Increase in oxidative stress can cause a variety of pathologic conditions including cancer, neurodegenerative 
diseases, and aging [117,118]. Excessive free radicals constantly attack DNA, proteins and lipids, leading to severe 
oxidative damage [119,120]. The presence of complex antioxidants, but usually not one or two, will scavenge the 
free radicals at various stages [6,7].  
 
A redox reaction or oxidation-reduction reaction is comprised of two parts, in which an oxidized half and a reduced 
half, and usually occur together. The oxidized half losses electrons while the reduced half gains electron. This 
usually continues, making a chain of redox reactions. 
 
From the literature review it might be conclude that the medicinal plants fruits and vegetables are nearly almost 
beneficial, but this is not the case for diet supplementations. The reason is not established yet, however, in the diets 
and medicinal plants, there are complex of antioxidants working as a continuous chain, while supplementation is 
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usually given using one or two antioxidants. Therefore, the antioxidant chain is not completely available [6,7]. It is 
known that after scavenging free radicals, if an antioxidant is not restored by the following antioxidant in the chain, 
it usually changes to a pro-oxidant. In this situation, the final effect of such supplementation would be no or a 
damaging effect [121]. This may explain that why in antioxidant therapy, complimentary antioxidants cannot always 
substitute the medicinal plants, fruits and vegetables high in antioxidants. 
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